Pascal d’Azemar

2.0k citations

13 papers · 1.5k indexed · 1 hit paper · h-index 9

Impact in

Internal Medicine top 0.2%
- Venous Thromboembolism Diagnosis and Management
Cardiology and Cardiovascular Medicine top 2%
- Atrial Fibrillation Management and Outcomes
- Acute Myocardial Infarction Research

Papers in ⓘ

Internal Medicine 10
- Venous Thromboembolism Diagnosis and Management 10
Cardiology and Cardiovascular Medicine 12
- Atrial Fibrillation Management and Outcomes 10
- Acute Myocardial Infarction Research 2

Co-authors: Luc Sagnard (3 shared papers)Gérald Simonneau (3 shared papers)Martin H. Prins (1 shared paper)Jan van der Meer (1 shared paper)Franco Piovella (1 shared paper)Desiderius P.M. Brandjes (1 shared paper)Harry R. Büller (1 shared paper)A.G.M. van den Belt (1 shared paper)
Journals: Thrombosis and Haemostasis (4 papers)Circulation (2 papers)Thrombosis Research (2 papers)New England Journal of Medicine (1 paper)European Journal of Clinical Pharmacology (1 paper)
Partner nations: France Netherlands Italy

In The Last Decade

Pascal d’Azemar

11 papers receiving 1.4k citations

Hit Papers

align trajectories log scale

Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at Home 1996 · 810 citations

Peers

Countries citing papers authored by Pascal d’Azemar

Since Specialization

Citations

This map shows the geographic impact of Pascal d’Azemar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal d’Azemar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal d’Azemar more than expected).

Fields of papers citing papers by Pascal d’Azemar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal d’Azemar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal d’Azemar. The network helps show where Pascal d’Azemar may publish in the future.

Co-authors

The 25 scholars most cited alongside Pascal d’Azemar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pascal d’Azemar Line = papers co-authored together Pascal d’Azemar links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work
1	Treatment of Venous Thrombosis with Intravenous Unfractionated Heparin Administered in the Hospital as Compared with Subcutaneous Low-Molecular-Weight Heparin Administered at Home New England Journal of Medicine ·Maria M.W. Koopman, Paolo Prandoni, Franco Piovella, Paul Ockelford, Desiderius P.M. Brandjes, Jan van der Meer, Alexander Gallus, Gérald Simonneau, Colin Chesterman, Martin H. Prins, Patrick M. Bossuyt, Hanneke de Haes, A.G.M. van den Belt, Luc Sagnard, Pascal d’Azemar, Harry R. Büller Hit paper breakdown →	1996	810
2	Low Molecular Weight Heparin and Compression Stockings in the Prevention of Venous Thromboembolism in Neurosurgery Thrombosis and Haemostasis ·Michael T. Nurmohamed, Andry Mampionona Riel, C M A Henkens, Mmw Koopman, G T H Que, Pascal d’Azemar, H.R. Büller, J W ten Cate, J A Hoek, J van der Meer, C van der Heul, A. G. G. Turpie, Susan L. Haley, Jane Sicurella, Michael Gent	1996	187
3	Systematic Lung Scans Reveal a High Frequency of Silent Pulmonary Embolism in Patients With Proximal Deep Venous Thrombosis Archives of Internal Medicine ·Michel Meignan, Jean Rosso, Hélène Gauthier, Françoise Brunengo, S Claudel, Luc Sagnard, Pascal d’Azemar, Gérald Simonneau, B Charbonnier	2000	169
4	Aging and Venous Thromboembolism Influence the Pharmacodynamics of the Anti-Factor Xa and Anti-thrombin Activities of a Low Molecular Weight Heparin (Nadroparin) Thrombosis and Haemostasis ·Patrick Mismetti, S Laporte‐Simitsidis, Christelle Navarro, Piérre Siè, Pascal d’Azemar, J Necciari, J Duret, Christine Gaud, Hervé Decousus, B Boneu	1998	78
5	Comparison of a once Daily with a twice Daily Subcutaneous Low Molecular Weight Heparin Regimen in the Treatment of Deep Vein Thrombosis Thrombosis and Haemostasis ·B Charbonnier, Jean‐Noël Fiessinger, JD Banga, E Wenzel, Pascal d’Azemar, Luc Sagnard, (unknown)	1998	72
6	Randomized trial of subcutaneous low-molecular-weight heparin CY 216 (Fraxiparine) compared with intravenous unfractionated heparin in the curative treatment of submassive pulmonary embolism. A dose-ranging study. Circulation ·C Théry, Gérald Simonneau, Guy Meyer, O. Hélénon, Françoise Bridey, C. Armagnac, Pascal d’Azemar, J.-P. Coquart	1992	66
7	Lack of effect of a low-molecular-weight heparin (nadroparin) on mortality in bedridden medical in-patients: a prospective randomised double-blind study European Journal of Clinical Pharmacology ·Isabelle Mahé, Jean‐François Bergmann, Pascal d’Azemar, J. J. Vaissie, C Caulin	2005	58
8	Effect of Nadroparin, a Low-Molecular-Weight Heparin, on Clinical and Angiographic Restenosis After Coronary Balloon Angioplasty Circulation ·Jean‐Marc Lablanche, Eugène McFadden, Nicolas Piriou, Jean René Lusson, Bernard Bertrand, Jean‐Philippe Metzger, Victor Legrand, Gilles Grollier, Carlos Macaya, Bernard De Bruyne, Alec Vahanian, Alain Grentzinger, C Masquet, Jean‐Eric Wolf, G Tobelem, Sylvie Fontecave, A Vacheron, Pascal d’Azemar, Michel E. Bertrand	1997	34
9	Pharmacodynamics of CY 216 in healthy volunteers: inter‐individual variations Fundamental and Clinical Pharmacology ·M Rostin, JL Montastruc, Georges Houin, Pascal d’Azemar, B Bayrou, B Boneu	1990	8
10	[Use in hemodialysis and hemofiltration of CY 216 (Fraxiparine) administered via intravenous bolus in patients with acute and chronic renal insufficiency with and without hemorrhagic risk]. PubMed ·Gerald Steinbach, C. Bosc, Caraman Pl, Élie Azoulay, L Olry, Pascal d’Azemar, J Chopin	1990	5
11	Influence of thromboembolism prophylaxis by low molecular weight heparin CY 216 (fraxiparine®) on several parameters of haemostasis in patients under dialysis and receiving either unfractionated heparin or CY 216 Thrombosis Research ·J Diéval, P Morinière, S. Groß, Pascal d’Azemar, A. Fournier, J Delobel	1990	2
12	INTER-INDIVIDUAL PHARMACOKINETIC VARIATIONS AFTER INTRAVENOUS (IV) AND SUBCUTANEOUS (SC) INJECTION OF CY 216 IN HEALTHY SUBJECTS Thrombosis and Haemostasis ·B Boneu, Georges Houin, M Rostin, J L Montastructure, Pascal d’Azemar, B Bayrou	1987	1
13	A randomized trial of subcutaneous low molecular weight heparin CY 216 D (fraxiparineR) compared with intravenous unfractionated heparin in the curative treatment of submassive pulmonary embolism (a dose-ranging study) Thrombosis Research ·G. Simonneau, C Théry, Guy Meyer, O. Hélénon, Françoise Bridey, C. Armagnac, Pascal d’Azemar, J.-P. Coquart	1992	1

About Pascal d’Azemar

Pascal d’Azemar is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine, Hematology, Emergency Medicine and Emergency Medical Services, having authored 13 papers that have together received 1.5k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (10 papers), Venous Thromboembolism Diagnosis and Management (10 papers), Heparin-Induced Thrombocytopenia and Thrombosis (4 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers), Intramuscular injections and effects (2 papers), Acute Myocardial Infarction Research (2 papers), Coronary Interventions and Diagnostics (1 paper) and Cardiac Imaging and Diagnostics (1 paper). The work is most often cited by research in Internal Medicine (1.3k citations), Cardiology and Cardiovascular Medicine (972 citations), Emergency Medical Services (259 citations), Hematology (237 citations) and Surgery (578 citations). Pascal d’Azemar has collaborated with scholars based in France, Netherlands and Italy. Frequent co-authors include Luc Sagnard, Gérald Simonneau, Martin H. Prins, Jan van der Meer, Franco Piovella, Desiderius P.M. Brandjes, Harry R. Büller, A.G.M. van den Belt, Hanneke de Haes and Maria M.W. Koopman. Their work appears in journals such as Thrombosis and Haemostasis, Circulation, Thrombosis Research, New England Journal of Medicine and European Journal of Clinical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact